Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,880
-$32,420 QoQ
Shares Held
6,500
-86.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 90 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ATYR ranks #341 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ATYR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,880 | 6,500 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $36,300 | 46,540 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $91,388 | 116,717 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $80,072 | 111,059 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,406,355 | 277,388 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $508,020 | 168,219 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $382,883 | 105,769 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,400 | 2,500 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,340 | 1,500 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,728 | 1,912 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,686 | 1,905 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,962 | 1,875 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,084 | 1,891 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,893 | 1,854 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,712 | 1,695 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,058 | 1,686 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,740 | 1,675 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,875 | 1,659 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,392 | 1,659 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,419 | 1,588 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $473 | 97 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $275 | 62 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $240 | 62 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $177 | 55 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $235 | 53 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $128 | 46 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||